题名

新冠肺炎大流行對C肝消除計畫的衝擊：隱藏性感染人口的診斷與治療

并列篇名

Impact of coronavirus disease 2019 pandemic on hepatitis C virus elimination: diagnosis and treatment in the hidden population with HCV infection

DOI

10.6288/TJPH.202106_40(3).PF03

作者

陳為堅(Wei J. Chen)

关键词
期刊名称

台灣公共衛生雜誌

卷期/出版年月

40卷3期（2021 / 06 / 28）

页次

241 - 244

内容语文

繁體中文
主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. Abdelwadoud, M,Mattingly, TJ, 2nd,Seguí, HA,Gorman, EF,Perfetto, EM(2020).Seguí HA, Gorman EF, Perfetto EM. Patient centeredness in hepatitis C direct-acting antiviral treatment delivery to people who inject drugs: a scoping review.Patient
  2. Afdhal, N,Zeuzem, S,Kwo, P(2014).Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.N Engl J Med,370,1889-1898.
  3. Becker, WC,Fiellin, DA(2020).When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis.Ann Intern Med,173,59-60.
  4. Blach, S,Kondili, LA,Aghemo, A(2021).Impact of OVID-19 on global HC Velimination efforts.J Hepatol,74,31-36.
  5. Buti, M,Domínguez-Hernández, R,Casado, MA(2021).Impact of the COVID-19 pandemicon HCV elimination in Spain.J Hepatol,74,1246-1248.
  6. Byrne, C,Radley, A,Inglis, SK(2020).Reaching m Etha done users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV).BMJ Open,10,e036501.
  7. Chen, DS(2019).Taiwan commits to eliminating hepatitis C in 2025.Lancet Infect Dis,19,466-467.
  8. Chevaliez, S.(2019).Strategies for the improvement of HCV testing and diagnosis.Expert Rev Anti Infect Ther,17,341-347.
  9. Crespo, J,Lázaro, P,Blasco, AJ(2021).Hepatitis C reflex testing in Spain in 2019: a story of success.Enferm Infecc Microbiol Clin,39,119-126.
  10. Ferenci, P,Bernstein, D,Lalezari, J(2014).ABT450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV.N Engl J Med,370,1983-1992.
  11. Gamkrelidze, I,Pawlotsky, JM,Lazarus, JV(2021).Progress towards hepatitis C virus elimination in high-income countries: an updated analysis.Liver Int,41,456-463.
  12. Huang, CF,Wu, PF,Yeh, ML(2021).Scaling up the inhospital hepatitis C virus care cascade in Taiwan.Clin Mol Hepatol,27,136-143.
  13. Jayadevappa, R.(2017).Patient-centered outcomes research and patient-centered care for older adults: a perspective.Gerontol Geriatr Med,3,2333721417700759.
  14. Li, CW,Yang, CJ,Sun, HY(2018).Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.PLoS One,13,e0194149.
  15. Liang, TJ,Ghany, MG(2014).Therapy of hepatitis C: back to the future.N Engl J Med,370,2043-2047.
  16. Liu, JY,Lin, HH,Liu, YC(2008).Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.Clin Infect Dis,46,1761-1768.
  17. Ng, MH,Chou, JY,Chang, TJ(2013).High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.Addict Behav,38,2089-2093.
  18. Picchio, CA,Valencia, J,Doran, J(2020).The impact of the COVID-19 pandemic on harm reduction services in Spain.Harm Reduct J,17,87.
  19. Rapoud, D,Quillet, C,Pham Minh, K(2020).Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).BMJ Open,10,e039234.
  20. Razavi, H,Gonzalez, YS,Yuen, C,Cornberg, M(2020).Response to Taiwan is on track of accelerating hepatitis C elimination by 2025.Liver Int,40,1507.
  21. Razavi, H,Sanchez Gonzalez, Y,Yuen, C,Cornberg, M(2020).Global timing of hepatitis C virus elimination in high-income countries.Liver Int,40,522-529.
  22. Saludes, V,Antuori, A,Folch, C(2019).Utility of a onestep screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.Int J Drug Policy,74,236-245.
  23. Shih, CC,Chen, Y,Shao, SC,Lai, EC(2020).Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan.Drug Alcohol Depend,217,108268.
  24. Volkow, ND(2020).Collision of the COVID-19 and addiction epidemics.Ann Intern Med,173,61-62.
  25. WHO(2016).Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis.Geneva:WHO.
  26. Wu, GH,Pwu, RF,Chen, SC(2018).Achieving hepatitis C elimination in Taiwan-overcoming barriers by setting feasible strategies.J Formos Med Assoc,117,1044-1045.
  27. Wu, GH,Pwu, RF,Chen, SC,Chen, DS(2020).Taiwan is on track of accelerating hepatitis C elimination by 2025.Liver Int,40,1506-1507.
  28. 衛生福利部, R.O.C. (Taiwan)(2019).國家消除C肝政策綱領2018-2025.台北=Taipei:衛生福利部=Ministry of Health and Welfare, R.O.C. (Taiwan).
print cancel